NEUROCRINE BIOSCIENCES, INC. Quotes Neurocrine Biosciences, Inc. Deutsche Boerse AG
Equities
NB3
US64125C1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129.7 EUR | +2.61% |
|
+4.26% | +9.13% |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 25/06/2024 | 26/06/2024 | 27/06/2024 | 28/06/2024 | |
|---|---|---|---|---|
| Last | 123.95 € | 127.6 € | 126.4 € | 129.7 € |
| Volume | 0 | 210 | 0 | 450 |
| Change | -0.96% | +2.94% | -0.94% | +2.61% |
| Opening | 123.95 | 125.55 | 126.40 | 124.95 |
| High | 123.95 | 127.75 | 126.40 | 129.70 |
| Low | 123.95 | 125.55 | 126.40 | 124.95 |
Performance
| 1 day | +2.61% | ||
| 1 week | +4.26% | ||
| Current month | +4.55% | ||
| 1 month | +0.58% | ||
| 3 months | +2.45% | ||
| 6 months | +9.18% | ||
| Current year | +9.13% | ||
| 1 year | +51.31% | ||
| 3 years | +55.11% | ||
| 5 years | +80.34% | ||
| 10 years | +1,101.15% |
Volumes
marketsDaily volume
450
Estimated daily volume
450
Avg. Volume 20 sessions
65
Daily volume ratio
6.92
Avg. Volume 20 sessions
8 430.50
Avg. Volume 20 sessions USD
9 030.08
Record volume 1
16 570
Record volume 2
16 562
Record volume 3
16 219
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
13 516 585 958
Capitalization (USD)
13 516 585 958
Net sales (USD)
1 887 100 000
Number of employees
1 448
Sales / Employee (USD)
1 303 246
Free-Float
98.2 %
Free-Float capitalization (EUR)
14 216 718 866
Free-Float capitalization (USD)
13 272 757 166
Average Daily Capital Traded
0%
Highs and lows
1 week
123.95
129.70
1 month
120.85129.70
Current year
118.25136.00
1 year
83.96136.00
3 years
63.54136.00
5 years
63.54136.00
10 years
9.35136.00
Indicators
Moving average 5 days
126.56
Moving average 20 days
124.38
Moving average 50 days
126.99
Moving average 100 days
126.31
Price spread / (MMA5)
-2.42%
Price spread / (MMA20)
-4.10%
Price spread / (MMA50)
-2.09%
Price spread / (MMA100)
-2.61%
STIM
RSI 9 days
54.81
RSI 14 days
52.15
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.61% | +4.26% | +9.13% | +51.31% | 13.52B | ||
| -0.80% | +0.00% | +15.20% | +33.62% | 122B | ||
| +0.02% | -0.20% | +19.67% | +50.14% | 113B | ||
| -1.87% | +9.90% | +18.95% | +16.51% | 26.49B | ||
| -0.02% | -5.06% | -23.86% | -24.83% | 19.4B | ||
| -1.88% | -3.38% | -19.03% | -31.05% | 16.24B | ||
| -2.00% | -8.61% | -20.90% | -20.68% | 15.4B | ||
| -0.36% | -3.21% | -46.14% | -37.44% | 15.15B | ||
| +0.03% | -1.69% | +63.85% | +41.18% | 14.93B | ||
| +0.07% | -1.46% | +116.20% | +232.51% | 10.79B | ||
| -4.14% | +0.76% | +20.24% | +46.79% | 8.57B | ||
| -0.83% | +3.94% | -26.39% | -36.91% | 8.14B | ||
| +2.65% | +16.29% | +139.15% | +279.79% | 7.77B | ||
| +0.72% | +6.67% | +8.28% | +56.79% | 7.77B | ||
| +0.96% | -1.82% | -3.56% | +25.54% | 7.38B | ||
| +1.41% | +1.57% | +41.67% | +53.01% | 6.57B | ||
| Average | -0.21% | +2.29% | +19.53% | +46.02% | ||
| Weighted average by Cap. | -0.42% | +0.65% | +15.66% | +37.30% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
1a150c4f6a948190a317949d4ac10683.H8IIZGrhSxJ7oOdD5IOEFmAxkOZPZpKBLiRbxtSu1gQ.b5ZZAQSEeCRL9Iwco9zCJzQA56IjX8jtWHwwo7ie-2hpg3pUXLEcdxj0iA
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | +9.13% | ||
| 2023 | +6.17% | ||
| 2022 | +51.52% | ||
| 2021 | -2.61% | ||
| 2020 | -22.77% | ||
| 2019 | +61.25% | ||
| 2018 | -3.11% | ||
| 2017 | +75.26% | ||
| 2016 | -29.23% | ||
| 2015 | +177.23% | ||
| 2014 | +171.25% | ||
| 2013 | +20.31% | ||
| 2012 | -14.85% | ||
| 2011 | +13.00% | ||
| 2010 | +191.10% | ||
| 2009 | -16.67% | ||
| 2008 | -20.00% | ||
| 2007 | -61.73% | ||
| 2006 | -85.14% | ||
| 2005 | +46.53% | ||
| 2004 | -17.88% | ||
| 2003 | -2.58% | ||
| 2002 | -24.11% | ||
| 2001 | +56.88% | ||
| 2000 | +23.93% |
- Stock Market
- Equities
- NBIX Stock
- NB3 Stock
- Quotes Neurocrine Biosciences, Inc.
